|
CNOT8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.354300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04919999999831E-05 |
| Normal-vs-Stage2 |
1.723700E-02 |
| Normal-vs-Stage3 |
1.757640E-01 |
| Normal-vs-Stage4 |
1.347960E-01 |
| Stage1-vs-Stage2 |
9.340400E-01 |
| Stage1-vs-Stage3 |
7.298300E-03 |
| Stage1-vs-Stage4 |
3.572400E-02 |
| Stage2-vs-Stage3 |
1.367780E-01 |
| Stage2-vs-Stage4 |
2.044400E-01 |
| Stage3-vs-Stage4 |
8.110400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.575650E-04 |
| Normal-vs-AfricanAmerican |
7.099400E-01 |
| Normal-vs-Asian |
2.138200E-01 |
| Caucasian-vs-AfricanAmerican |
2.314200E-02 |
| Caucasian-vs-Asian |
9.397600E-01 |
| AfricanAmerican-vs-Asian |
3.875800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.222800E-04 |
| Normal-vs-Female |
8.340000E-03 |
| Male-vs-Female |
4.032400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.097200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.443270E-04 |
| Normal-vs-Age(61-80Yrs) |
8.782400E-03 |
| Normal-vs-Age(81-100Yrs) |
6.732000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.785400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.698000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.253200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.056170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.649000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.082000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.775000E-04 |
| Normal-vs-Grade 2 |
2.81769999999071E-06 |
| Normal-vs-Grade 3 |
4.362300E-02 |
| Normal-vs-Grade 4 |
5.273600E-01 |
| Grade 1-vs-Grade 2 |
4.394600E-01 |
| Grade 1-vs-Grade 3 |
2.245900E-02 |
| Grade 1-vs-Grade 4 |
1.410330E-02 |
| Grade 2-vs-Grade 3 |
1.737460E-03 |
| Grade 2-vs-Grade 4 |
9.389800E-04 |
| Grade 3-vs-Grade 4 |
2.299200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.93899999787217E-08 |
| Normal-vs-ccB subtype |
1.786030E-01 |
| ccA subtype-vs-ccB subtype |
1.68352999999621E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.198000E-03 |
| Normal-vs-N1 |
4.478000E-01 |
| N0-vs-N1 |
5.114800E-01 |
|
|
